News Focus
News Focus
Followers 8
Posts 744
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 1464

Wednesday, 08/01/2007 9:02:58 AM

Wednesday, August 01, 2007 9:02:58 AM

Post# of 2446
Brookwood...

Dew, I agree, this acquisition looks good to me on first blush...

See: http://www.brookwoodpharma.com/ for an introduction to Brookwood Pharmaceuticals and its background.

Brookwood was spunout from Southern Research on Jan 19, 2005 to focus upon time-release pharmaceutical formulations. It had developed a commercially injectiable microsphere product while part of Southern Research.

With the spin-off, Brookwood retained its relationship with Carrington’s DelSite subsidiary to develop GelSite, a high molecular weight anionic polysaccharide that provides controlled release of peptides.

Brookwood also has developed a relationship with Genzyme Pharmaceuticals. Genzyme has developed LipoBridge as a delivery technology to facilitate transfer across the blood-brain barrier, and LipoMask to increase circulation half-lives.

On May 7, 2007, Brookwood formed a collaborative joint venture with Targeted Technology Ventures (Aeon Bioscience) to develop new DES technology.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRDX News